Gunther Kauselmann
Artemis
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gunther Kauselmann.
Biology of Reproduction | 2009
Christiane Otto; Iris Fuchs; Gunther Kauselmann; Heidrun Kern; Branko Zevnik; Puk Andreasen; Gilda Schwarz; Helga Altmann; Mario Klewer; Richardus Vonk; Karl-Heinrich Fritzemeier
Abstract The G protein-coupled receptor Gpr30 (Gper) was recently claimed to bind to estradiol and to activate cytoplasmic signal transduction pathways in response to estradiol. However, there are conflicting data regarding the role of Gpr30 as an estrogen receptor (ER): several laboratories were unable to demonstrate estradiol binding to GPR30 or estradiol-activated signal transduction in Gpr30-expressing cells. To clarify the potential role of Gpr30 as an ER, we generated Gpr30-deficient mice. Although Gpr30 was expressed in all reproductive organs, histopathological analysis did not reveal any abnormalities in these organs in Gpr30-deficient mice. Mutant male and female mice were as fertile as their wild-type littermates, indicating normal function of the hypothalamic-pituitary-gonadal axis. Moreover, we analyzed estrogenic responses in two major estradiol target organs, the uterus and the mammary gland. For that purpose, we examined different readout paradigms such as morphological measures, cellular proliferation, and target gene expression. Our data demonstrate that in vivo Gpr30 is dispensable for the mediation of estradiol effects in reproductive organs. These results are in clear contrast to the phenotype of mice lacking the classic ER alpha (Esr1) or aromatase (Cyp19a1). We conclude that the perception of Gpr30 (based on homology related to peptide receptors) as an ER might be premature and has to be reconsidered.
The EMBO Journal | 1999
Gunther Kauselmann; Markus Weiler; Peer Wulff; Sebastian Jessberger; Uwe Konietzko; Joey Scafidi; Ursula Staubli; Jürgen Bereiter-Hahn; Klaus Strebhardt; Dietmar Kuhl
In order to stabilize changes in synaptic strength, neurons activate a program of gene expression that results in alterations of their molecular composition and structure. Here we demonstrate that Fnk and Snk, two members of the polo family of cell cycle associated kinases, are co‐opted by the brain to serve in this program. Stimuli that produce synaptic plasticity, including those that evoke long‐term potentiation (LTP), dramatically increase levels of both kinase mRNAs. Induced Fnk and Snk proteins are targeted to the dendrites of activated neurons, suggesting that they mediate phosphorylation of proteins in this compartment. Moreover, a conserved C‐terminal domain in these kinases is shown to interact specifically with Cib, a Ca2+‐ and integrin‐binding protein. Together, these studies suggest a novel signal transduction mechanism in the stabilization of long‐term synaptic plasticity.
PLOS ONE | 2009
Antje Willuweit; Joachim Velden; Robert Godemann; André Manook; Fritz Jetzek; Hartmut Tintrup; Gunther Kauselmann; Branko Zevnik; Gjermund Henriksen; Alexander Drzezga; Johannes Pohlner; Michael Schoor; John A. Kemp; Heinz Von Der Kammer
Background Transgenic mice expressing mutated amyloid precursor protein (APP) and presenilin (PS)-1 or -2 have been successfully used to model cerebral β-amyloidosis, one of the characteristic hallmarks of Alzheimers disease (AD) pathology. However, the use of many transgenic lines is limited by premature death, low breeding efficiencies and late onset and high inter-animal variability of the pathology, creating a need for improved animal models. Here we describe the detailed characterization of a new homozygous double-transgenic mouse line that addresses most of these issues. Methodology/Principal Findings The transgenic mouse line (ARTE10) was generated by co-integration of two transgenes carrying the K670N/M671L mutated amyloid precursor protein (APPswe) and the M146V mutated presenilin 1 (PS1) both under control of a neuron-specific promoter. Mice, hemi- as well as homozygous for both transgenes, are viable and fertile with good breeding capabilities and a low rate of premature death. They develop robust AD-like cerebral β-amyloid plaque pathology with glial inflammation, signs of neuritic dystrophy and cerebral amyloid angiopathy. Using our novel image analysis algorithm for semi-automatic quantification of plaque burden, we demonstrate an early onset and progressive plaque deposition starting at 3 months of age in homozygous mice with low inter-animal variability and 100%-penetrance of the phenotype. The plaques are readily detected in vivo by PiB, the standard human PET tracer for AD. In addition, ARTE10 mice display early loss of synaptic markers and age-related cognitive deficits. By applying a γ-secretase inhibitor we show a dose dependent reduction of soluble amyloid β levels in the brain. Conclusions ARTE10 mice develop a cerebral β-amyloidosis closely resembling the β-amyloid-related aspects of human AD neuropathology. Unifying several advantages of previous transgenic models, this line particularly qualifies for the use in target validation and for evaluating potential diagnostic or therapeutic agents targeting the amyloid pathology of AD.
Molecular and Cellular Biology | 2003
Frieder Schwenk; Branko Zevnik; Jens C. Brüning; Mathias Röhl; Antje Willuweit; Anja Rode; Thomas Hennek; Gunther Kauselmann; Rudolf Jaenisch; Ralf Kühn
ABSTRACT ES cell-tetraploid (ES) mice are completely derived from embryonic stem cells and can be obtained at high efficiency upon injection of hybrid ES cells into tetraploid blastocysts. This method allows the immediate generation of targeted mouse mutants from genetically modified ES cell clones, in contrast to the standard protocol, which involves the production of chimeras and several breeding steps. To provide a baseline for the analysis of ES mouse mutants, we performed a phenotypic characterization of wild-type B6129S6F1 ES mice in relation to controls of the same age, sex, and genotype raised from normal matings. The comparison of 90 morphological, physiological, and behavioral parameters revealed elevated body weight and hematocrit as the only major difference of ES mice, which exhibited an otherwise normal phenotype. We further demonstrate that ES mouse mutants can be produced from mutant hybrid ES cells and analyzed within a period of only 4 months. Thus, ES mouse technology is a valid research tool for rapidly elucidating gene function in vivo.
Genes & Cancer | 2011
Danielle R. Cook; Patricia A. Solski; Scott J. Bultman; Gunther Kauselmann; Michael Schoor; Ralf Kuehn; Lori S. Friedman; Dale O. Cowley; Terry Van Dyke; Jen Jen Yeh; Leisa Johnson; Channing J. Der
Ect2 is a member of the human Dbl family of guanine nucleotide exchange factors (RhoGEFs) that serve as activators of Rho family small GTPases. Although Ect2 is one of at least 25 RhoGEFs that can activate the RhoA small GTPase, cell culture studies using established cell lines determined that Ect2 is essential for mammalian cell cytokinesis and proliferation. To address the function of Ect2 in normal mammalian development, we performed gene targeting to generate Ect2 knockout mice. The heterozygous Ect2(+/-) mice showed normal development and life span, indicating that Ect2 haplodeficiency was not deleterious for development or growth. In contrast, Ect2(-/-) embryos were not found at birth or postimplantation stages. Ect2(-/-) blastocysts were recovered at embryonic day 3.5 but did not give rise to viable outgrowths in culture, indicating that Ect2 is required for peri-implantation development. To further assess the importance of Ect2 in normal cell physiology, we isolated primary fibroblasts from Ect2(fl/fl) embryos (MEFs) and ablated Ect2 using adenoviral delivery of Cre recombinase. We observed a significant increase in multinucleated cells and accumulation of cells in G2/M phase, consistent with a role for Ect2 in cytokinesis. Ect2 deficiency also caused enlargement of the cytoplasm and impaired cell migration. Finally, although Ect2-dependent activation of RhoA has been implicated in cytokinesis, Ect2 can also activate Rac1 and Cdc42 to cause growth transformation. Surprisingly, ectopic expression of constitutively activated RhoA, Rac1, or Cdc42, known substrates of Ect2, failed to phenocopy Ect2 and did not rescue the defect in cytokinesis caused by loss of Ect2. In summary, our results establish the unique role of Ect2 in development and normal cell proliferation.
PLOS ONE | 2014
Branko Zevnik; Nathalie C. Uyttersprot; Ana V. Perez; Gerald W. M. Bothe; Heidrun Kern; Gunther Kauselmann
We generated C57BL/6NTac mice carrying a tyrosinase loss-of function mutation and a reversion of the nonagouti locus to agouti. This strain has a high superovulation response, allows visual detection of chimeric coat color contribution of C57BL/6 ES-cells and provides a simplified breeding format that generates black G1 offspring of pure inbred C57BL/6 background in one step, providing the ideal host for genetically manipulated C57BL/6 ES cells.
Nucleic Acids Research | 2003
Jost Seibler; Branko Zevnik; Birgit Küter-Luks; Susanne Andreas; Heidrun Kern; Thomas Hennek; Anja Rode; Cornelia Heimann; Nicole Faust; Gunther Kauselmann; Rudolf Jaenisch; Klaus Rajewsky; Ralf Kühn; Frieder Schwenk
Archive | 2003
Helen Francis-Lang; Lori Friedman; Marcia Belvin; Gregory D. Plowman; Jeffrey S. Larson; Changyou Chen; Stephanie A. Roberston; Mario N. Lioubin; Wen Shi; Jocelyn Chan; Roel P. Funke; Danxi Li; Gunther Kauselmann; Hartmut Tintrup; Branko Zevnik; Michael Schoor; Brian John Reardon
Archive | 2004
Gunther Kauselmann; Branko Zevnik; Jost Seibler; Heidrun Kern
Nature Methods | 2007
Gunther Kauselmann; Heidrun Kern; Anne Klein-Vehne; Torsten Müller; Annette Pfennig; Branko Zevnik